128 related articles for article (PubMed ID: 36149153)
1. Can dual staining with p16 and Ki67 be biomarkers of epithelial dysplasia in oral lesions?
Bharti A; Qayoom S; Jaiswal R; Agarwal P; Singh RK; Agarwal SP; Bhalla S; Makker A; Goel MM
J Cancer Res Ther; 2022; 18(4):1003-1008. PubMed ID: 36149153
[TBL] [Abstract][Full Text] [Related]
2. P16 and Ki67 immunostaining is a useful adjunct in the assessment of biopsies for HPV-associated anal intraepithelial neoplasia.
Walts AE; Lechago J; Bose S
Am J Surg Pathol; 2006 Jul; 30(7):795-801. PubMed ID: 16819320
[TBL] [Abstract][Full Text] [Related]
3. Expression of p16 in oral cancer and premalignant lesions.
Buajeeb W; Poomsawat S; Punyasingh J; Sanguansin S
J Oral Pathol Med; 2009 Jan; 38(1):104-8. PubMed ID: 19192055
[TBL] [Abstract][Full Text] [Related]
4. Investigation of p16(INK4a) as a prognostic biomarker in oral epithelial dysplasia.
Nankivell P; Williams H; Webster K; Pearson D; High A; MacLennan K; Senguven B; McConkey C; Rabbitts P; Mehanna H
J Oral Pathol Med; 2014 Apr; 43(4):245-9. PubMed ID: 24372672
[TBL] [Abstract][Full Text] [Related]
5. Usefulness of p16/Ki67 immunostaining in the triage of women referred to colposcopy.
Ordi J; Sagasta A; Munmany M; Rodríguez-Carunchio L; Torné A; del Pino M
Cancer Cytopathol; 2014 Mar; 122(3):227-35. PubMed ID: 24757722
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of p16INK4 is a reliable marker of human papillomavirus-induced oral high-grade squamous dysplasia.
Cunningham LL; Pagano GM; Li M; Tandon R; Holm SW; White DK; Lele SM
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2006 Jul; 102(1):77-81. PubMed ID: 16831676
[TBL] [Abstract][Full Text] [Related]
7. Combination of p16(INK4a) /Ki67 immunocytology and HPV polymerase chain reaction for the noninvasive analysis of HPV involvement in head and neck cancer.
Linxweiler M; Bochen F; Wemmert S; Lerner C; Hasenfus A; Bohle RM; Al-Kadah B; Takacs ZF; Smola S; Schick B
Cancer Cytopathol; 2015 Apr; 123(4):219-29. PubMed ID: 25557267
[TBL] [Abstract][Full Text] [Related]
8. Ki-67, cyclin E, and p16INK4 are complimentary surrogate biomarkers for human papilloma virus-related cervical neoplasia.
Keating JT; Cviko A; Riethdorf S; Riethdorf L; Quade BJ; Sun D; Duensing S; Sheets EE; Munger K; Crum CP
Am J Surg Pathol; 2001 Jul; 25(7):884-91. PubMed ID: 11420459
[TBL] [Abstract][Full Text] [Related]
9. Co-expression of p53 and Ki67 and lack of EBV expression in oral squamous cell carcinoma.
Iamaroon A; Khemaleelakul U; Pongsiriwet S; Pintong J
J Oral Pathol Med; 2004 Jan; 33(1):30-6. PubMed ID: 14675138
[TBL] [Abstract][Full Text] [Related]
10. Aberrant expression of p53, p16INK4a and Ki-67 as basic biomarker for malignant progression of oral leukoplakias.
Nasser W; Flechtenmacher C; Holzinger D; Hofele C; Bosch FX
J Oral Pathol Med; 2011 Sep; 40(8):629-35. PubMed ID: 21435003
[TBL] [Abstract][Full Text] [Related]
11. [Determination of human papillomavirus in oral leukoplakia,oral lichen planus and oral squamous cell carcinoma].
Cao J; Jin JQ; Deng DJ; Liu HW
Beijing Da Xue Xue Bao Yi Xue Ban; 2016 Feb; 48(1):84-8. PubMed ID: 26885914
[TBL] [Abstract][Full Text] [Related]
12. p16/Ki67 dual staining improves the detection specificity of high-grade cervical lesions.
Zhang R; Ge X; You K; Guo Y; Guo H; Wang Y; Geng L
J Obstet Gynaecol Res; 2018 Nov; 44(11):2077-2084. PubMed ID: 30094887
[TBL] [Abstract][Full Text] [Related]
13. Expression of Human Papillomavirus and the p16 Gene in Oral Potentially Malignant Disorders (OPMD): a Comparative Study With Oral Squamous Cell Carcinoma.
Baddevithana AK; Jayasinghe RD; Tilakaratne WM; Illeperuma RP; Siriwardena BSMS
Appl Immunohistochem Mol Morphol; 2023 May-Jun 01; 31(5):331-338. PubMed ID: 37036407
[TBL] [Abstract][Full Text] [Related]
14. Frequency and role of HPV in the progression of epithelial dysplasia to oral cancer.
Angiero F; Gatta LB; Seramondi R; Berenzi A; Benetti A; Magistro S; Ordesi P; Grigolato P; Dessy E
Anticancer Res; 2010 Sep; 30(9):3435-40. PubMed ID: 20944119
[TBL] [Abstract][Full Text] [Related]
15. [The p16 methylation in oral leukoplakia and oral squamous cell carcinoma].
Liu HW; Hu BQ; Cao CF
Zhonghua Kou Qiang Yi Xue Za Zhi; 2005 Mar; 40(2):94-7. PubMed ID: 15842853
[TBL] [Abstract][Full Text] [Related]
16. [P16(INK4alpha)/Ki-67 immunocytochemical dual staining for detection of cervical lesions associated to papillomavirus infection].
Toro de Méndez M; Ferrández Izquierdo A; Llombart-Bosch A
Invest Clin; 2014 Sep; 55(3):238-48. PubMed ID: 25272523
[TBL] [Abstract][Full Text] [Related]
17. Comparative evaluation of immunohistochemical expression of MCM2 and Ki67 in oral epithelial dysplasia and oral squamous cell carcinoma.
Swain S; Nishat R; Ramachandran S; Raghuvanshi M; Behura SS; Kumar H
J Cancer Res Ther; 2022; 18(4):997-1002. PubMed ID: 36149152
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical expression of p53, p16 and hTERT in oral squamous cell carcinoma and potentially malignant disorders.
Abrahao AC; Bonelli BV; Nunes FD; Dias EP; Cabral MG
Braz Oral Res; 2011; 25(1):34-41. PubMed ID: 21359449
[TBL] [Abstract][Full Text] [Related]
19. Actual proliferating index in oral squamous cell carcinoma and leukoplakia.
Chandak AR; Gadbail AR; Chaudhary MS; Chandak SA; Wadhwani R
J Investig Clin Dent; 2011 Aug; 2(3):176-83. PubMed ID: 25426788
[TBL] [Abstract][Full Text] [Related]
20. Performance of p16/Ki67 immunostaining, HPV E6/E7 mRNA testing, and HPV DNA assay to detect high-grade cervical dysplasia in women with ASCUS.
Zhu Y; Ren C; Yang L; Zhang X; Liu L; Wang Z
BMC Cancer; 2019 Mar; 19(1):271. PubMed ID: 30917784
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]